The opportunity ahead for Phlexglobal is significant, and I look forward to accelerating the company’s growth trajectory and market leadership.”
-John McNeill, CEO Phlexglobal

Amersham, UK; Malvern, PA. — January 14, 2019 — Phlexglobal today announced that its Board of Directors has appointed John McNeill as Chief Executive Officer and member of the Board of Directors effective January 14, 2019. McNeill previously held the position of President at Sparta Systems, Inc.
“John McNeill is ideally placed to lead Phlexglobal”, said Rick Riegel. “John is a proven life sciences industry veteran with demonstrated leadership, customer focus, product understanding and results. His vision for success will greatly benefit Phlexglobal as the company enters its next stage of further innovation and growth.” In addition to the appointment of John McNeill as CEO, Phlexglobal also announced that Rick Riegel has moved to the position of Vice-Chairman.
Prior to joining Phlexglobal, McNeill was a key member of the executive team at Sparta Systems for 7 years, helping to build out Sparta’s market leading and global solution for quality management systems for the life sciences and other regulated industries. During his tenure, Sparta increased market share and successfully transitioned to a cloud-based SaaS business model. Prior to Sparta, John held leadership positions at IRI, BravoSolution, and VerticalNet.
Shifting the Lens: Why a Portfolio View is the Missing Piece in TMF Oversight At CDISC Europe 2026, we explored a simple but important idea: the challenge with TMF metrics isn’t what we measure -
As a first-time attendee of the CDISC conference, this year held in Milan, I had the great opportunity to meet like-minded and influential figures in the space, as well as present my poster on TMF
This year’s CDISC conference in Milan was especially meaningful for me. It was my first time attending, and I had the privilege of presenting alongside Jason Weinstein from Regeneron, a long-time
UK: +44 (0) 1494 720420
US: +1 (484) 324-7921
Poland: +48 81 45 46 132
Germany: +49 89 23514741